Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics.

about

Perspectives of Phage-Eukaryotic Cell Interactions to Control Epstein-Barr Virus Infections.“Hard” Drug Repurposing for Precision Oncology: The Missing Link?Nitazoxanide, an antiprotozoal drug, inhibits late-stage autophagy and promotes ING1-induced cell cycle arrest in glioblastoma

P2860

Q53694309-2C5CBCD1-15EE-4A71-805A-E324B719631B Q55371416-BCBAFA8E-F55F-46BC-A11F-0740FF93D731 Q57287856-4940137F-89FB-4E39-A731-08EEE54F89FB

P2860

Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics.

Item

http://www.wikidata.org/entity/Q49562067

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Giving Drugs a Second Chance: ...... Drugs As Cancer Therapeutics.

@en

Giving Drugs a Second Chance: ...... Drugs As Cancer Therapeutics.

@nl

type

Item

label

Giving Drugs a Second Chance: ...... Drugs As Cancer Therapeutics.

@en

Giving Drugs a Second Chance: ...... Drugs As Cancer Therapeutics.

@nl

prefLabel

Giving Drugs a Second Chance: ...... Drugs As Cancer Therapeutics.

@en

Giving Drugs a Second Chance: ...... Drugs As Cancer Therapeutics.

@nl

P1476

Giving Drugs a Second Chance: ...... Drugs As Cancer Therapeutics.

@en

P2093

Connor Yanchus

http://www.w3.org/2001/XMLSchema#string

J Javier Hernandez

http://www.w3.org/2001/XMLSchema#string

Lindsay Smith

http://www.w3.org/2001/XMLSchema#string

Michael Pryszlak

http://www.w3.org/2001/XMLSchema#string

Naheed Kurji

http://www.w3.org/2001/XMLSchema#string

Vijay M Shahani

http://www.w3.org/2001/XMLSchema#string

P2860

Trifluoperazine for schizophrenia

Computational and Practical Aspects of Drug Repositioning

Opportunities and Challenges for Drug Development: Public-Private Partnerships, Adaptive Designs and Big Data

Health plan utilization and costs of specialty drugs within 4 chronic conditions

Gene expression-based chemical genomics identifies potential therapeutic drugs in hepatocellular carcinoma

In Silico Identification and In Vitro and In Vivo Validation of Anti-Psychotic Drug Fluspirilene as a Potential CDK2 Inhibitor and a Candidate Anti-Cancer Drug

A survey of current trends in computational drug repositioning

The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease

Drug repositioning: identifying and developing new uses for existing drugs

Identification of repurposed small molecule drugs for chordoma therapy.

P304

273

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FONC.2017.00273

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Steven Molinski

P577

2017-11-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29184849

http://www.w3.org/2001/XMLSchema#string

P932

5694537

http://www.w3.org/2001/XMLSchema#string

Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics.

about

P2860

P2860

Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932